NeoDynamics has introduced its new precision biopsy system, NeoNavia® for ultrasound-guided breast biopsies.

Advances in breast cancer screening, imaging, and breast cancer treatments have created new demands for developing new technologies for tissue sampling in breasts and axillary lymph nodes.

An innovative biopsy system

NeoNavia is an innovative biopsy system built on a patented pulse technology for controlled and precise needle insertion and is based on research at the Karolinska Institutet in Sweden. The system was developed by NeoDynamics AB and is now being commercially introduced into the first markets.


Patented pulse technology developed at the Karolinska Institute

  • Control & precision during needle insertion

  • Stabilisation of the lesion during tissue sampling

  • FlexiPulse gave 299% higher tissue yield than a standard 14G CNB

  • Maintain control throughout the procedure

  • Less tissue deformation compared to standard devices

More Information

For more information on NeoDynamics please visit their website